A new study looking at sleep-disordered breathing and markers for Alzheimer's disease risk in cerebrospinal fluid and neuroimaging adds to the growing body of research linking the two. But this latest study also poses an interesting question: Could AD in its "preclinical stages" also lead to SDB and explain the increased prevalence of SDB in the elderly?
Emergency physicians are key decisionmakers for nearly half of all hospital admissions, highlighting a critical role they can play in reducing health care costs, according to a new report from the RAND Corporation. Hospital admissions from the ER increased by 17 percent over seven years, accounting for nearly all the growth in hospital admissions between 2003 and 2009.
The study comprised over 24,000 Finnish subjects and was led by Professor Samuli Ripatti. The results revealed that a panel of 28 genetic markers improved detection of individuals with high risk for coronary heart disease (CHD) (10-year risk ≥20%) over traditional risk factors.
EL SEGUNDO, Calif., May 20, 2013 /PRNewswire/ -- A medical diagnostic technology that experts at Wyle helped perfect for use both in space and on Earth was inducted recently in the Space Technology Hall of Fame. The technology assures high quality, secure handling and transmission of...
Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced that its Nellcor™ pulse oximetry portfolio, which is used to measure arterial oxygen saturation, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for motion claims.
PENTAX Medical Continues Global Leadership in Endoscopic Ultrasound Systems with Release of the Hi Vision PreirusMay 20, 2013 11:08 am | by PENTAX Medical Company | Comments
PENTAX Medical Company, a healthcare industry leader in endoscopic imaging, recently announced the release of the HI VISION™ Preirus™ ultrasound scanner. PENTAX Medical, in collaboration with Hitachi-Aloka, has had a rich history of introducing ultrasound scanners to the gastroenterology and pulmonary markets that present new possibilities in imaging capabilities.
New Diagnostics Solutions from Welch Allyn to Help Improve Patient Safety, Reduce Risk for FacilitiesMay 20, 2013 11:05 am | by Welch Allyn | Comments
Welch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, will showcase its new FlexiPort® EcoCuffTM blood pressure cuff and EarlySense Vitals Surveillance System at the National Teaching Institute & Critical Care Exposition this week at the Boston Convention & Exhibition Center in Boston, Mass.
Given Imaging Announces New Data Confirming SmartPill Improves Diagnosis and Clinical Management of Patients With Motility IssuesMay 20, 2013 11:02 am | by Globe Newswire | Comments
Given Imaging Ltd, a world leader in GI medical devices and pioneer of capsule endoscopy, has announced several studies confirming an expanded role for SmartPill in diagnosing gastrointestinal motility disorders. All data were presented at Digestive Disease Week taking place May 18 - 21, 2013 at the Orange County Convention Center, Orlando, FL where Given Imaging is exhibiting at booth #1059 throughout the conference.
BioMatrix NeoFlex features a new advanced stent delivery system, improving pushability, trackability, and crossability. It also has a lower lesion entry profile than its predecessor. BioMatrix NeoFlex retains the same combination of abluminal biodegradable polymer coating, proprietary limus drug Biolimus A9, and platform that has made the BioMatrix stent family an increasingly popular choice of DES in global markets where available.
EDAP's Ablatherm-HIFU Demonstrates Long Term Efficacy, Durability and Reproducibility With Prospective Fourteen -Year StudyMay 20, 2013 10:46 am | by GlobeNewswire | Comments
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today new long term data demonstrating high rates of both cancer-specific and overall survival of patients treated with high-intensity focused ultrasound. The study led by Drs. Sebastien Crouzet and Albert Gelet of Edouard Herriot Hospital, located in Lyon, France evaluated the morbidity and long term oncologic outcomes of primary HIFU therapy for localized prostate cancer.
CardioDx Announces Publication of the IMPACT-CARD Trial Demonstrating Use of Corus@ CAD Test Influenced Cardiologists' Clinical Management of Patients with Symptoms Suggestive of Obstructive Coronary Artery DiseaseMay 20, 2013 8:31 am | by The Associated Press | Comments
CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced the publication of the IMPACT-CARD (Investigation of a Molecular Personalized Coronary Gene Expression Test on Cardiology Practice Pattern) trial in Critical Pathways in Cardiology. This prospective...
The Ohio State University Commences Key Comparative Study of Vycor's Patented ViewSite Brain Access SystemMay 20, 2013 8:30 am | by The Associated Press | Comments
Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), a medical device company with a suite of FDA approved products, announced today that the Minimally Invasive Cranial Surgery Program at the Ohio State University (Columbus, OH) has commenced an animal study to evaluate a comparison of tissue damage...
Sotera Wireless@, creator of the ViSi Mobile@ wireless patient monitoring system, announced today that Intermountain Healthcare will officially partner with the Company. Furthering this collaboration, Intermountain Healthcare executive vice president and chief financial officer Bert Zimmerli ...
NISKAYUNA, N.Y.--(BUSINESS WIRE)--May 20, 2013--To commemorate National Cancer Research Month, a team of scientists from GE Global Research, the technology development arm of the General Electric Co. (NYSE: GE), are joined together in a technology “relay race” against cancer. They collectively are...
FRAMINGHAM, Mass.--(BUSINESS WIRE)--May 20, 2013--AB SCIEX, a global leader in analytical technologies, today announced the launch of the 3200MD CE-IVDD series for general in vitro diagnostic use in Europe. Meeting regulatory requirements to obtain the CE-IVDD mark for the new AB SCIEX API...